PRODUCTION OF RECOMBINANT MOUSE CARBONIC ANHYDRASES PROTEINS

Agnė Mikelevičiūtė1, Tautvydas Kojis1, Aurelija Mickevičiūtė1, Lina Baranauskienė1

1 Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania

Carbonic anhydrases (CA) responsible for reversible carbon dioxide's hydration in recent years have become one of the emerging therapeutic targets. However, carbonic anhydrases are linked to many diseases and disorders because of their importance in many physiological processes such as pH regulation, ion transport, or metabolic reactions, where bicarbonate is used as a substrate [1]. For example, CA I is associated with anemia; CA II and CA IV with glaucoma; and CA IX with cancer [2].

Several CA inhibitors are used to control glaucoma, epilepsy, edema, etc. Moreover, one of the important discoveries in recent years was carbonic anhydrase isozyme, specifically CA IX, connection to cancer. Some of the inhibitors for CA IX have already entered preclinical or clinical trials [2]. In the preclinical research step, new drug testing is performed on animals. House mouse (Mus musculus) is the most often used model organism for preclinical drug testing. While orthologous proteins are highly similar, sometimes even small structural differences result in significant affinity variations towards small molecule inhibitors. By producing murine carbonic anhydrases (Car), we will be able to test whether human CA inhibitors that were selected using in vitro methods have comparable affinity and selectivity to murine Car, and thus we could expect more accurate results in the preclinical testing.

Previously we produced several recombinant mouse carbonic anhydrases [3] [4]. Now we were able to produce most of the active mouse carbonic anhydrases. Most of them were expressed in different Escherichia coli strains and purified by chromatographic methods. Their expression and purity have been confirmed using SDS-PAGE (Fig. 1).

Figure 1
Fig. 1. SDS-PAGE of carbonic anhydrases (from left to right protein marker, Car I, Car II, Car III, Car IV, Car VA, Car VI, Car VII, Car XIII).

[1] Chegwidden W.R. (2021) The Carbonic Anhydrases in Health and Disease. In: Chegwidden W.R., Carter N.D. (eds) The Carbonic Anhydrases: Current and Emerging Therapeutic Targets. Progress in Drug Research, vol 75. Springer, Cham. https://doi.org/10.1007/978-3-030-79511-5_1.

[2] Matulis, D. (Ed.). (2019). Carbonic Anhydrase as Drug Target. doi:10.1007/978-3-030-12780-0.

[3] E. Timoščenka, Production of recombinant mouse carbonic anhydrases Car I, Car II, Car III, Car VII, Car XIII, 64th international conference for students of physics and natural sciences, Open Readings 2021.

[4] T. Kojis, Production of recombinant mouse carbonic anhydrase Car XIV protein, 64th international conference for students of physics and natural sciences, Open Readings 2021.